News & Events
Everli’s Path to Nasdaq
Pre-money equity value
$180M
Expected tickers
EVRL · EVRLW
Extraordinary General Meeting
October 22, 2026
Redemption deadline
October 20, 2026
Transaction Timeline
July 30, 2025
Merger Agreement Signed
Everli and Melar enter into a definitive Agreement and Plan of Merger.
July 31, 2025
Transaction Announced
Business combination valuing Everli at a $180 million pre-money equity value.
August 21, 2026
Form S-4 Filed
Registration statement filed with the SEC.
September 28, 2026
Record Date
Shareholders of record at close of business may vote.
October 2, 2026
Registration Statement Effective
SEC declares Form S-4 (File No. 333-298505) effective.
October 20, 2026 at 5:00 PM EDT
Redemption Deadline
5:00 p.m. ET, two business days before the meeting.
October 22, 2026 at 8:00 AM EDT
Extraordinary General Meeting
Melar shareholders vote on the business combination.
Expected
Closing & Nasdaq Listing
Expected shortly after the meeting, subject to closing conditions. Trading as EVRL / EVRLW.
Securities
- Before closingMACI · Melar Class A ordinary sharesAfter closingEVRL · Everli Class A common stock
- Before closingMACIW · Melar warrantsAfter closingEVRLW · Everli warrants
Voting and Redemptions
Vote Your Shares
The meeting will be held on October 22, 2026 at 8:00 AM EDT at Ellenoff Grossman & Schole LLP, 1345 Avenue of the Americas, 11th Floor, New York, NY 10105. Melar’s board unanimously recommends voting “FOR” each proposal. For assistance, contact the proxy solicitor:
Advantage Proxy, Inc.
(877) 870-8565 (toll free) · (206) 870-8565
ksmith@advantageproxy.com
Redemption Rights
Holders of Melar Class A ordinary shares who wish to exercise redemption rights must submit a request to Continental Stock Transfer & Trust Company by October 20, 2026 at 5:00 PM EDT, following the procedures described in the definitive proxy statement/prospectus.
Continental Stock Transfer & Trust Company (opens in a new tab)
Announcements
Transaction Documents
No offer or solicitation. This page is not a proxy statement or a solicitation of a proxy, consent or authorization with respect to any securities or the business combination, and is not an offer to sell or a solicitation of an offer to buy any securities. Shareholders are urged to read the definitive proxy statement/prospectus and other documents filed with the SEC carefully and in their entirety, because they contain important information about Melar, Everli and the business combination. Copies are available free of charge at www.sec.gov.
Forward-looking statements. Statements regarding the expected timing of the meeting, the closing of the business combination and the listing of the combined company’s securities are forward-looking and subject to risks and uncertainties described in the “Risk Factors” section of the registration statement.